Innovations in Science
MDA Medical Education
MDA offers a series of educational programs developed for clinicians and specialists who manage and treat individuals with neuromuscular disease. The Medical Education team has partnered with the country’s top thought leaders and experts to create a series of educational programs including CME-certified Grand Round webinars, peer-to-peer educational slide decks and case studies. See below for a listing of all Medical Education programs.
The Medical Education team will be updating the hub regularly as new programs become available. To receive updates as new programs are available, and to receive our Monthly Report for clinicians and researchers, click here.
For any questions about programs offered please contact MedEd@mdausa.org.
In an effort to support awareness of enrolling neuromuscular disease clinical studies, the Medical Education team provides a service to promote national-level/multi-center clinical studies seeking participants. Newly enrolling studies are announced via the MDA Quest blog, e-mail, social media, and posted to MDA.org.
- View enrolling studies
- Submit a request to have your study included (NOTE: Only IRB-approved studies are eligible for this program)
MDA's Clinician Industry Update Webinars are programs which provide an opportunity for clinicians to receive information and updates impacting their clinical practice directly from pharmaceutical, biotechnology and medical equipment companies. Topics covered may include information on current clinical trials, drug development and the information impacting patients' experience.
Developed in conjunction with expert thought leaders, the Considerations in Care Case Studies explore multidisciplinary clinical decision making through the lens of in-depth experiences of people living with various neuromuscular diseases.
Featuring expert thought leaders across neuromuscular diseases, the MDA Grand Rounds Webinars include best practices and practical clinical considerations in the management and care of individuals with neuromuscular disease. Many programs are available for CME credit.
The MDA Monthly Report eNewsletter provides a summary of recent and important updates and events for clinicians and researchers working in neuromuscular disease.
MedShr neuromuscular disorders discussion group provides a secure, trusted environment for case discussion and medical education that protects patient privacy and confidentiality. MDA brings the opportunity to reach and connect with other neuromuscular disease clinicians to support and optimize patient care. You will be able to post cases for discussion, ask questions, share knowledge, and connect with peers.
As part of our commitment to provide relevant, timely and impactful clinical education, MDA conducts a series of short briefings of emerging topics/events that have the capacity to impact neuromuscular disease care. The What’s New in NMD Series is designed to help clinicians across all disciplines stay up-to-date on factors that impact clinical care.
Expert-crafted speaker slide series on current topics in the neuromuscular disease space, the Peer-to-Peer Educational Slide Sets may be leveraged for peer-to-peer educational programs and used as reference materials.
If you are a clinician who is interested in partnering with MDA on education or have suggestions for new content, please reach out to email@example.com
Copyright 2022 Muscular Dystrophy Association. All rights reserved. The Medical Education Program(s) in their entirety (including, but not limited to: webinar(s), speaker deck presentation(s), MDA Monthly Report content and case studies) are owned by Muscular Dystrophy Association and the associated partner(s) and may not be copied, reproduced, or altered in any manner without MDA’s prior written consent except that the User(s) may download, view, or use these program(s) for educational purposes only.
If you wish to alter any of the Medical Education Program(s) presented by the MDA in a form other than what is set out on mda.org, please consult firstname.lastname@example.org.